august 24 2025 glp-1 The Trump Administration's Nov. 6 announcement to significantly reduce the cost of medications marks an important step toward improving access to evidence-based obesity treatment. These medications can support an average 15% Alarming rise in weight loss
Description
PlexusDx helps patients navigate semaglutide therapy after cholecystectomy with personalized dosing and genetic insights
GLP-1 is the hormone targeted by Ozempic to reduce appetite and promote satiety
PlexusDx offers dual-compound GLP-1 formulations designed for personalized weight management
These headwinds have led to a sharp decline in its stock price, raising questions about the long-term impact of its gamble.
For GLP-1 Users: GLP-1 medications actively slow gastric emptying, frequently leading to stubborn constipation
